Grifols, S.A.
MSE:GRF.MC
9.85 (EUR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Grifols, S.A. |
Symbool | GRF.MC |
Munteenheid | EUR |
Prijs | 9.846 |
Beurswaarde | 6,148,458,189 |
Dividendpercentage | 0% |
52-weken bereik | 6.362 - 15.92 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Thomas H. Glanzmann |
Website | https://www.grifols.com |
An error occurred while fetching data.
Over Grifols, S.A.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)